摘要:
The present invention relates to Angiopoietin-3 (Ang-3) and Angiopoietin-4 (Ang-4). The present invention also relates to methods of modulating an activity of Ang-3 or Ang-4. The present invention further relates to methods of treating cancer, diabetes, and arthritis.
摘要:
The present invention relates to Angiopoietin-3 (Ang-3) and Angiopoietin-4 (Ang-4). The present invention also relates to methods of modulating an activity of Ang-3 or Ang-4. The present invention further relates to methods of treating cancer, diabetes, and arthritis.
摘要:
The present invention relates to Angiopoietin-3 (Ang-3) and Angiopoietin-4 (Ang-4). The present invention also relates to methods of modulating an activity of Ang-3 or Ang-4. The present invention further relates to methods of treating cancer, diabetes, and arthritis.
摘要:
The present invention relates to Angiopoietin-3 (Ang-3) and Angiopoietin-4 (Ang-4). The present invention also relates to methods of modulating an activity of Ang-3 or Ang-4. The present invention further relates to methods of treating cancer, diabetes, and arthritis.
摘要:
The present invention provides a light string with reinforced wires. The light string includes a plurality of reinforced wires and a plurality of lamps electrically connected in series via the plurality of reinforced wires. Each reinforced wire includes a plurality of conducting wires, an outer insulating sheath covering the plurality of conducting wires and one or more reinforcing strands configured between an inner side surface and an outer side surface of the outer insulating sheath and extending along a direction parallel to a central longitudinal axis of the reinforced wire. The bending resistant performance of the electric wire between each two adjacent lamps is improved greatly, the fatigue strength of the electric wire is much better than that of an ordinary electric wire, and the tensile strength of the electric wire is improved.
摘要:
Disclosed is a method, system, and program product for providing an efficient mechanism to provide updateable relational views over XML. This will allow application developers to write both queries and updates using a relational (SQL) syntax, even though the underlying data is stored as XML. According to some approaches, this is accomplished by implementing a reverse mapping from the data within the views to the node addresses of the corresponding data in the underlying XML document.
摘要:
The present invention relates to ADAMTS-1 and uses thereof. The present invention also relates to fragments of ADAMTS-1 and methods of inhibiting cell growth and metastasis. The present invention also provide methods of identifying inhibitors and activators relating to the function of ADAMTS-1.
摘要:
Pharmaceutical compositions that comprise a pharmaceutically acceptable carrier and either a therapeutically effective amount of an ECM-binding fragment of Ang-1 protein at comprises SEQ ID NO:1 and/or SEQ ID NO:2 or a homologous peptide thereof and pharmaceutical compositions that comprise a pharmaceutically acceptable carrier and a vector comprising a nucleic acid molecule that comprises the nucleotide sequence that encodes an ECM-binding fragment of Ang-1 protein that comprises SEQ ID NO:1 and/or SEQ ID NO:2 or a homologous peptide thereof are disclosed. Methods of using such compositions to treat individuals suspected of having coronary artery disease, vascular disease or a condition involving ischemia and to promote angiogenesis, endothelial survival and maintaining vascular integrity are disclosed. Methods to identify compounds that modulates binding of Ang-1 to ECM are disclosed. Pharmaceutical compositions which comprise a therapeutically effective amount of Ang-2 protein and/or a vector comprising a nucleic acid molecule that comprises the nucleotide coding sequence of Ang-2 and methods of using such compositions to treat individuals suspected of having cancer are disclosed.
摘要翻译:包含药学上可接受的载体和治疗有效量的Ang-1蛋白的ECM结合片段的药物组合物包含SEQ ID NO:1和/或SEQ ID NO:2或其同源肽和包含 药学上可接受的载体和载体,其包含核酸分子,其包含编码包含SEQ ID NO:1和/或SEQ ID NO:2或其同源肽的Ang-1蛋白的ECM结合片段的核苷酸序列 披露 公开了使用这些组合物治疗怀疑有冠状动脉疾病,血管疾病或涉及缺血的病症并促进血管发生,内皮存活和维持血管完整性的方法。 公开了鉴定调节Ang-1与ECM结合的化合物的方法。 公开了包含治疗有效量的Ang-2蛋白和/或包含含有Ang-2的核苷酸编码序列的核酸分子的载体的药物组合物和使用该组合物治疗疑似患有癌症的个体的方法。
摘要:
A request to execute a query is received in a database system. In response, the database system determines that a collection of data elements to be returned by the query corresponds to a first data structure not defined within a type dictionary of the database system. The database system obtains attribute values that describe respective data fields within the first data structure, and records, within the type dictionary, a first data type definition that specifies the data fields described by the attribute values.
摘要:
Techniques for partitioning nested tables are provided. A parent table includes a column for collection items. A nested table is created for storing items that belong to the collection items. The nested table is partitioned to create a plurality of nested table partitions. Each nested table partition is a distinct, separately stored structure within a database. How the nested table is partitioned may, or may not, be based on how the parent table is partitioned. For example, a nested table may be partitioned based on the same criteria in which the parent table is partitioned. As another example, a nested table may be partitioned, whereas the parent table is not partitioned.